​

Evolus Ownership | Who Owns Evolus?

OverviewForecastRevenueFinancialsChartTranscripts

Evolus Ownership Summary

Evolus is owned by 30.19% institutional investors, 13.55% insiders, and 56.26% retail investors. Nantahala capital management is the largest institutional shareholder, holding 8.99% of EOLS shares. BioPharma Credit Ord is the top mutual fund, with 8.78% of its assets in Evolus shares.

EOLS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEvolus30.19%13.55%56.26%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.82%11.62%67.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nantahala capital management5.82M8.99%$38.71M
Tang capital management5.49M8.50%$33.70M
Blackrock4.01M6.82%$43.49M
Caligan partners lp4.14M6.41%$25.41M
Blackrock funding, inc. /de4.10M6.33%$27.23M
Vanguard group3.34M5.16%$22.22M
Frazier life sciences management2.63M4.08%$16.15M
Stonepine capital management1.54M2.38%$9.43M
State street1.52M2.35%$9.30M
Eversept partners, lp1.48M2.29%$9.06M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management1.54M7.67%$9.43M
Allostery investments lp60.00K7.04%$552.60K
Awh capital625.00K4.00%$3.84M
Caligan partners lp4.14M3.33%$25.41M
Altium capital management lp685.00K2.15%$7.56M
Cm management250.00K1.40%$1.66M
Tang capital management5.49M1.30%$33.70M
Nantahala capital management5.82M1.28%$38.71M
Soviero asset management, lp330.00K1.05%$2.03M
Potomac capital management141.17K0.75%$938.79M

Top Buyers

HolderShares% AssetsChange
Caligan partners lp4.14M3.33%796.97K
Blackrock4.01M0.00%747.40K
Stonepine capital management1.54M7.67%619.89K
Bnp paribas arbitrage, snc564.99K0.00%493.45K
Tang capital management5.49M1.30%490.90K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---2.47M
Frontier capital management270.51K0.01%-1.39M
Tri locum partners lp---1.24M
Soros fund management---995.49K
Nuveen88.37K0.00%-983.00K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp428.65K0.01%428.65K$2.85M
Soviero asset management, lp330.00K1.05%330.00K$2.03M
Caption management247.60K0.01%247.60K$1.52M
Prospect capital advisors208.10K0.66%208.10K$1.28M
Potomac capital management141.17K0.75%141.17K$938.79M

Sold Out

HolderChange
National bank of canada /fi/-2.00
True wealth design-4.00
Coldstream capital management-12.00
Lindbrook capital-21.00
Jpl wealth management-23.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202594-43.37%19,539,863-64.07%300.42%54-32.50%21-61.11%
Sep 30, 202571-60.77%16,258,044-72.12%250.31%35-61.96%19-62.75%
Jun 30, 2025180-1.64%58,292,2378.05%901.26%915.81%51-15.00%
Mar 31, 20251839.58%54,281,2874.55%851.26%864.88%6129.79%
Dec 31, 202451-69.82%10,920,539-78.29%170.27%22-73.81%14-68.89%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
BioPharma Credit Ord5.66M8.78%-99.14K
Vanguard US Total Market Shares ETF1.68M2.65%-
Vanguard Total Stock Mkt Idx Inv1.67M2.57%-
iShares Russell 2000 ETF1.29M2.00%553.44K
Schroder US Smaller Companies Acc718.22K1.11%-15.14K
Vanguard Institutional Extnd Mkt Idx Tr717.47K1.11%3.90K
Oberweis Micro-Cap Growth677.60K1.05%-
Oberweis Micro-Cap677.60K1.05%-
Fidelity Small Cap Index594.92K0.92%10.50K
Xtrackers S&P 500 Swap ETF 1C578.12K0.92%-153.31K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 22, 2025MOATAZEDI DAVID See RemarksSell$75.36K
Dec 22, 2025Avelar Rui See RemarksSell$16.17K
Aug 22, 2025Yamagishi-Dressler Tomoko Chief Marketing OfficerSell$42.97K
Aug 15, 2025Stewart Brady-Buy$204.49K
Jun 16, 2025MOATAZEDI DAVID See RemarksSell$164.05K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4-2
2025 Q311
2025 Q215
2025 Q1-6

EOLS Ownership FAQ

Who Owns Evolus?

Evolus shareholders are primarily institutional investors at 30.19%, followed by 13.55% insiders and 56.26% retail investors. The average institutional ownership in Evolus's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Evolus exceeds.

Who owns the most shares of Evolus?

Evolus’s largest shareholders are Nantahala capital management (5.82M shares, 8.99%), Tang capital management (5.49M shares, 8.50%), and Blackrock (4.01M shares, 6.82%). Together, they hold 24.31% of Evolus’s total shares outstanding.

Does Blackrock own Evolus?

Yes, BlackRock owns 6.82% of Evolus, totaling 4.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 43.49M$. In the last quarter, BlackRock increased its holdings by 747.4K shares, a 22.92% change.

Who is Evolus’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is Evolus’s biggest shareholder by percentage of total assets invested, with 7.67% of its assets in 1.54M Evolus shares, valued at 9.43M$.

Who is the top mutual fund holder of Evolus shares?

BioPharma Credit Ord is the top mutual fund holder of Evolus shares, with 8.78% of its total shares outstanding invested in 5.66M Evolus shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools